182 related articles for article (PubMed ID: 29165389)
1. Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling.
Ungefroren H; Witte D; Rauch BH; Settmacher U; Lehnert H; Gieseler F; Kaufmann R
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165389
[TBL] [Abstract][Full Text] [Related]
2. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
[TBL] [Abstract][Full Text] [Related]
3. Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.
Ungefroren H; Gieseler F; Kaufmann R; Settmacher U; Lehnert H; Rauch BH
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29795022
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-
Ungefroren H; Witte D; Mihara K; Rauch BH; Henklein P; Jöhren O; Bonni S; Settmacher U; Lehnert H; Hollenberg MD; Kaufmann R; Gieseler F
Mol Pharmacol; 2017 Nov; 92(5):519-532. PubMed ID: 28842394
[TBL] [Abstract][Full Text] [Related]
5. The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.
Ungefroren H; Witte D; Fiedler C; Gädeken T; Kaufmann R; Lehnert H; Gieseler F; Rauch BH
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261154
[TBL] [Abstract][Full Text] [Related]
6. Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer.
Witte D; Zeeh F; Gädeken T; Gieseler F; Rauch BH; Settmacher U; Kaufmann R; Lehnert H; Ungefroren H
J Clin Med; 2016 Nov; 5(12):. PubMed ID: 27916875
[TBL] [Abstract][Full Text] [Related]
7. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
8. Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis.
Chung H; Ramachandran R; Hollenberg MD; Muruve DA
J Biol Chem; 2013 Dec; 288(52):37319-31. PubMed ID: 24253040
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta signaling in cancer invasion and metastasis.
Leivonen SK; Kähäri VM
Int J Cancer; 2007 Nov; 121(10):2119-24. PubMed ID: 17849476
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.
Kong J; Du J; Wang Y; Yang M; Gao J; Wei X; Fang W; Zhan J; Zhang H
Oncotarget; 2016 Nov; 7(46):76224-76237. PubMed ID: 27776350
[TBL] [Abstract][Full Text] [Related]
12. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
[TBL] [Abstract][Full Text] [Related]
13. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1 induces proteinase-activated receptor 2 (PAR2) expression in endometriotic stromal cells and stimulates PAR2 activation-induced secretion of IL-6.
Saito A; Osuga Y; Yoshino O; Takamura M; Hirata T; Hirota Y; Koga K; Harada M; Takemura Y; Yano T; Taketani Y
Hum Reprod; 2011 Jul; 26(7):1892-8. PubMed ID: 21546388
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Gieseler F; Ungefroren H
Mol Cancer; 2015 Nov; 14():199. PubMed ID: 26588899
[TBL] [Abstract][Full Text] [Related]
16. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
17. TGF-β signaling in cancer.
Gu S; Feng XH
Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):941-949. PubMed ID: 30165534
[TBL] [Abstract][Full Text] [Related]
18. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Thacker PC; Karunagaran D
PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
[TBL] [Abstract][Full Text] [Related]
19. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
[TBL] [Abstract][Full Text] [Related]
20. TGF-β Signaling in Cancer.
Syed V
J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
